Wells Fargo
AZN icon

Wells Fargo’s AstraZeneca AZN Stock Holding History

Wells Fargo’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305M Sell
1,544,632
-6,794
-0.4% -$1.31M 0.06% 280
2025
Q4 		$285M Sell
1,551,426
-85,910
-5% -$15.1M 0.05% 300
2025
Q3 		$251M Buy
1,637,336
+23,083
+1% +$3.49M 0.05% 321
2025
Q2 		$226M Buy
1,614,253
+49,714
+3% +$6.97M 0.05% 329
2025
Q1 		$230M Sell
1,564,539
-40,808
-3% -$5.9M 0.05% 304
2024
Q4 		$210M Sell
1,605,347
-84,034
-5% -$11.8M 0.05% 317
2024
Q3 		$263M Sell
1,689,381
-154,061
-8% -$24.9M 0.06% 268
2024
Q2 		$288M Buy
1,843,442
+291,749
+19% +$43.9M 0.07% 240
2024
Q1 		$210M Buy
1,551,693
+28,996
+2% +$3.84M 0.05% 296
2023
Q4 		$205M Buy
1,522,697
+102,402
+7% +$13.3M 0.05% 291
2023
Q3 		$192M Buy
1,420,295
+48,150
+4% +$6.58M 0.06% 279
2023
Q2 		$196M Sell
1,372,145
-7,131
-0.5% -$1.05M 0.05% 282
2023
Q1 		$191M Buy
1,379,276
+237,531
+21% +$32M 0.06% 278
2022
Q4 		$155M Sell
1,141,745
-51,040
-4% -$6.4M 0.05% 331
2022
Q3 		$131M Buy
1,192,785
+14,556
+1% +$1.85M 0.04% 333
2022
Q2 		$156M Buy
1,178,229
+31,647
+3% +$4.15M 0.05% 317
2022
Q1 		$152M Buy
1,146,582
+368,038
+47% +$44.1M 0.04% 361
2021
Q4 		$90.7M Buy
778,544
+8,986
+1% +$1.06M 0.02% 523
2021
Q3 		$92.4M Buy
769,558
+77,923
+11% +$9.07M 0.02% 703
2021
Q2 		$82.9M Sell
691,635
-132,838
-16% -$14.6M 0.02% 783
2021
Q1 		$82M Sell
824,473
-132,481
-14% -$13.3M 0.02% 784
2020
Q4 		$95.7M Sell
956,954
-246,644
-20% -$26.1M 0.02% 662
2020
Q3 		$132M Buy
1,203,598
+89,716
+8% +$9.98M 0.04% 448
2020
Q2 		$118M Buy
1,113,882
+57,463
+5% +$5.93M 0.03% 474
2020
Q1 		$94.4M Sell
1,056,419
-31,876
-3% -$3M 0.03% 477
2019
Q4 		$109M Sell
1,088,295
-4,037
-0.4% -$380K 0.03% 554
2019
Q3 		$97.4M Buy
1,092,332
+59,655
+6% +$5.17M 0.03% 578
2019
Q2 		$85.3M Sell
1,032,677
-210,588
-17% -$16.5M 0.02% 653
2019
Q1 		$101M Sell
1,243,265
-275,963
-18% -$21.8M 0.03% 556
2018
Q4 		$115M Sell
1,519,228
-138,750
-8% -$10.8M 0.04% 464
2018
Q3 		$131M Sell
1,657,978
-230,138
-12% -$17.4M 0.04% 485
2018
Q2 		$133M Sell
1,888,116
-55,239
-3% -$3.97M 0.04% 476
2018
Q1 		$136M Sell
1,943,355
-207,264
-10% -$14.4M 0.04% 456
2017
Q4 		$149M Sell
2,150,619
-52,793
-2% -$3.56M 0.04% 424
2017
Q3 		$149M Buy
2,203,412
+152,294
+7% +$9.62M 0.05% 414
2017
Q2 		$140M Buy
2,051,118
+17,109
+0.8% +$1.12M 0.04% 423
2017
Q1 		$127M Buy
2,034,009
+648,080
+47% +$37.7M 0.04% 455
2016
Q4 		$75.7M Sell
1,385,929
-296,823
-18% -$16.9M 0.03% 626
2016
Q3 		$111M Buy
1,682,752
+614,166
+57% +$40.1M 0.04% 476
2016
Q2 		$64.5M Buy
1,068,586
+141,502
+15% +$8.22M 0.03% 634
2016
Q1 		$52.2M Sell
927,084
-77,863
-8% -$4.68M 0.02% 738
2015
Q4 		$68.2M Buy
1,004,947
+70,884
+8% +$4.65M 0.03% 617
2015
Q3 		$59.4M Buy
934,063
+150,570
+19% +$9.91M 0.02% 668
2015
Q2 		$49.9M Buy
783,493
+201,923
+35% +$13.8M 0.02% 809
2015
Q1 		$39.8M Buy
581,570
+4,539
+0.8% +$315K 0.02% 918
2014
Q4 		$40.6M Buy
577,031
+15,822
+3% +$1.13M 0.02% 875
2014
Q3 		$40.1M Sell
561,209
-22,639
-4% -$1.66M 0.02% 850
2014
Q2 		$43.4M Sell
583,848
-806,903
-58% -$58.3M 0.02% 843
2014
Q1 		$90.2M Sell
1,390,751
-116,897
-8% -$7.55M 0.04% 498
2013
Q4 		$89.5M Sell
1,507,648
-44,712
-3% -$2.43M 0.04% 482
2013
Q3 		$80.6M Buy
1,552,360
+34,987
+2% +$1.76M 0.04% 493
2013
Q2 		$71.8M Buy
+1,517,373
New +$77.3M 0.04% 499

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Wells Fargo's AZN Position: Q1 2026 in Review

Wells Fargo reduced its AstraZeneca (AZN) stake by 0.44% in Q1 2026, selling an estimated $1.31M and leaving 1,544,632 shares worth $305M. The position accounts for 0.06% of the portfolio, ranked #280.

Wells Fargo first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Wells Fargo held 1,544,632 shares of AstraZeneca worth $305M as of Q1 2026.
  • Wells Fargo sold 6,794 AstraZeneca shares in Q1 2026, an estimated $1.31M.
  • AstraZeneca made up 0.06% of Wells Fargo's portfolio in Q1 2026, its #280 holding.
  • Wells Fargo first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.